Bronchial Diseases  >>  ciprofloxacin (Q3939)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT00930982 / 2009-009869-34: Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Completed
2
124
US, Europe, RoW
Ciprofloxacin (Cipro, BAYQ3939), Placebo
Bayer, Novartis
Bronchiectasis
09/10
09/10

Download Options